The FDA accepted a supplemental new drug application to expand the indication for Ryzumvi to include the treatment of ...

Opus Genetics and Viatris, Inc. (Viatris) (through its affiliate) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for ...

Phentolamine ophthalmic solution 0.75% shows significant near vision improvement in patients with presbyopia during the phase 3 VEGA-3 clinical trial.

TECLens treated the first patient in a first-in-human trial assessing safety and efficacy of qCXL-based refractive correction ...

Advanced technology lenses work best in pristine eyes. Problems with ocular alignment, pupil size, ocular surface disease, irregular astigmatism, corneal dystrophies, scarring, and diseases of the ...

Presbyopia is a decline in your vision when your eyes lose the ability to focus on things close to you. In spite of the big name, it isn't a disease. It's a natural part of the aging process, and it's ...

Presbyopia is, unfortunately, an inevitable condition associated with aging. Almost everyone over the age of 45 experiences this near-sight vision loss, which gradually gets worse and usually requires ...

There are multiple treatment options for presbyopia, from simple solutions such as reading glasses or contact lenses to more complex procedures such as refractive eye surgery. Presbyopia is the ...

It’s possible to have presbyopia and astigmatism at the same time. Treatments such as prescription contacts or glasses and eye surgery can help correct both conditions. Astigmatism and presbyopia are ...

Presbyopia is an eye condition that causes a reduced ability to see things up close. It occurs when the eye’s lens stops focusing light correctly on the retina and usually develops later in life. The ...